MP22 Policy for prescribing anti-psychotic medications in psychotic conditions (excluding Bipolar Disorder)


Category
Medicine management
Code
MP22
Issue No
1

Target Audience

All clinical staff

Purpose

The Antipsychotic Task & Finish Group, Prescribers within the Trust have been consulted with at various events, such as the Masterclass in Psychopharmacology study day and local Consultant & Managers (CONMAN) meetings, to give their opinion regarding antipsychotic prescribing

Origin

Lead executive
Medical Director

Author and contact number
Lead Clinical Pharmacist
01625 663857


Policy dates & history

Implementation Date

30 November 2011

Review Date

30 November 2016

Approval Meeting

Medicines Management Group (MMG)

Ratification

Document Quality Group (DQG)


Appendices

Download

MP22 Policy for prescribing antipsychotic medications in psychotic conditions excluding Bipolar Disorder Issue 1.pdf

0.21MB
Download Now
Text size A- A+
Contrast options